HALO logo
halo search icon
NuCana plc Sponsored ADR
NuCana plc Sponsored ADR
NCNA · NAS

NuCana plc Sponsored ADR

US$2.04

Price Arrow0.06 (3.03%)
20/05/2026 04:00:00 PM
All-ConsensusBig CandleHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

NuCana plc Sponsored ADR Overview

NCNA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About NCNA

icon

Telephone

44.131.357.1111

icon

Address

3 Lochside Way, Edinburgh, Midlothian EH12 9DT

Description

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

NCNA Price Chart

Key Stats

Market Cap

US$8.24M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.33 - 40

Trade Value (12mth)

US$1,294,607.00

1 week

-9.17%

1 month

-8.76%

YTD

-45.6%

1 year

-75.5%

All time high

160000.00

Key Fundamentals

EPS 3 yr Growth

-99.60%

EBITDA Margin

0.00%

Operating Cashflow

-£7m

Free Cash Flow Return

-45.50%

ROIC

-187.80%

Interest Coverage

NaN

Quick Ratio

5.60

Other Data

Shares Outstanding (Fully Diluted)

4m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

GBP

Short Sell (% of issue)

0.00

NCNA Announcements

Latest Announcements

DateAnnouncements
15 May 26
07 May 26
07 January 26
18 December 25
11 December 25

NCNA Fundamentals

Per Share Records

Historical data

Forecast data

GBP2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
£locklocklocklock-2,626.08-1,279.99-13.05locklocklock
EPS (Fully Diluted)
£locklocklocklock-2,626.08-1,279.99-13.05locklocklock
Growth
%locklocklocklock1451.399locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of NuCana plc Sponsored ADR (NCNA:NAS)?
Halo FAQ
The current share price of NuCana plc Sponsored ADR (NCNA:NAS) is USD$2.04.
What is the 52-week high share price for NuCana plc Sponsored ADR (NCNA:NAS)?
Halo FAQ
The 52-week high share price for NuCana plc Sponsored ADR (NCNA:NAS) is USD$40.00.
What is the 52-week low share price for NuCana plc Sponsored ADR (NCNA:NAS)?
Halo FAQ
The 52-week low share price for NuCana plc Sponsored ADR (NCNA:NAS) is USD$1.33.
What is the dividend yield for NuCana plc Sponsored ADR (NCNA:NAS)?
Halo FAQ
NuCana plc Sponsored ADR (NCNA:NAS) does not pay a dividend.
What was NuCana plc Sponsored ADR (NCNA:NAS) last dividend payment?
Halo FAQ
NuCana plc Sponsored ADR (NCNA:NAS) does not pay a dividend.
What is the franking level for NuCana plc Sponsored ADR (NCNA:NAS)?
Halo FAQ
NuCana plc Sponsored ADR (NCNA:NAS) has a franking level of 0.00%.
In which sector is NuCana plc Sponsored ADR (NCNA:NAS) classified?
Halo FAQ
NuCana plc Sponsored ADR (NCNA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.